Bioequivalence guideline for capecitabine makes public
Published: 2010-07-05 06:58:00
Updated: 2010-07-05 06:58:00
The Korea Food and Drug Administration has published a new bioequivalence guideline for capecitabine tablets, defining that generic makers should conduct the above testing in patients with colorectal cancers breast cancer, for whom any medications are unnecessary.
The drug agency said this gui...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
